Widespread transcriptomic alterations of transient receptor potential channel genes in cancer

Tao Pan1, Yueying Gao1, Gang Xu1

  • 1Hainan Provincial Key Laboratory for Human Reproductive Medicine and Genetic Research, Hainan Provincial Clinical Research Center for Thalassemia, Key Laboratory of Reproductive Health Diseases Research and Translation (Hainan Medical University), Ministry of Education, Department of Reproductive Medicine, the First Affliated Hospital of Hainan Medical University, College of Biomedical Information and Engineering, Hainan Medical University, Haikou, Hainan 571199, China.

Insights

Transient Receptor Potential (TRP) channels are vital genes implicated in cancer. This study reveals widespread TRP gene dysregulation across 33 cancer types, impacting patient survival and offering new therapeutic targets.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Ion channels, particularly Transient Receptor Potential (TRP) channels, are crucial for physiological functions.
  • Growing evidence links TRP genes to various diseases, including diverse cancer types.
  • A comprehensive understanding of TRP gene expression alterations across the cancer landscape is lacking.

Purpose of the Study:

  • To comprehensively review and summarize the transcriptomic landscape of TRP genes across a wide range of cancer types.
  • To investigate the association between TRP gene dysregulation and clinical outcomes in cancer patients.
  • To explore the functional implications of TRP gene alterations in cancer and other diseases.

Main Methods:

  • Analysis of transcriptomic data from over 10,000 samples across 33 distinct cancer types.
  • Systematic review of recent studies on the functions of TRP family gene alterations.
  • Correlation analysis between TRP gene expression patterns and patient survival data.

Main Results:

  • Widespread transcriptomic dysregulation of TRP genes was observed across numerous cancer types.
  • Altered TRP gene expression significantly correlated with clinical survival in cancer patients.
  • Perturbations in TRP genes were associated with key cancer-related pathways.

Conclusions:

  • TRP genes exhibit extensive transcriptomic alterations in cancer, influencing patient prognosis.
  • Understanding these alterations provides insights into cancer pathogenesis.
  • This comprehensive review highlights the potential of TRP genes as therapeutic targets for cancer therapy and precision medicine.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K